Protego
3 known investors
Protego Bio develops first-in-class small molecule pharmacological chaperones designed to restore protein function and treat protein misfolding diseases such as cardiomyopathy and AL amyloidosis. The company combines protein sciences, computation, and medicinal chemistry to advance drug discovery programs from target identification through clinical validation.
AI & Machine LearningBiotechDeep Tech